0001493152-24-008818.txt : 20240305 0001493152-24-008818.hdr.sgml : 20240305 20240305103332 ACCESSION NUMBER: 0001493152-24-008818 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240229 FILED AS OF DATE: 20240305 DATE AS OF CHANGE: 20240305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bentovim Lyron L CENTRAL INDEX KEY: 0001326879 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40556 FILM NUMBER: 24718683 MAIL ADDRESS: STREET 1: 60 CUTTER MILL ROAD STREET 2: GREAT NECK CITY: NEW YORK STATE: NY ZIP: 11021 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Glimpse Group, Inc. CENTRAL INDEX KEY: 0001854445 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING SERVICES [7371] ORGANIZATION NAME: 06 Technology IRS NUMBER: 812958271 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 15 WEST 38TH ST, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: 917-292-2685 MAIL ADDRESS: STREET 1: 15 WEST 38TH ST, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 4 1 ownership.xml X0508 4 2024-02-29 0 0001854445 Glimpse Group, Inc. VRAR 0001326879 Bentovim Lyron L 15 WEST 38TH ST, 12TH FLOOR NEW YORK NY 10018 1 1 0 0 President and CEO 0 Stock Option (Right to Purchase) 2024-02-29 2024-02-29 4 D 0 90188 0 D Common Stock 90188 0 D Stock Option (Right to Purchase) 2024-03-01 2024-03-01 4 A 0 72153 0 A 2031-03-01 Common Stock 72153 1282153 D Represents the forfeiture of fully vested options to purchase an aggregate of 90,188 shares of common stock granted under the issuer's 2016 equity incentive plan, as amended (the "2016 Plan"), consisting of options to purchase (i) 32,508 shares of common stock granted on August 1, 2018 with an exercise price of $4.00/share, (ii) 6,037 shares of common stock and 4,799 shares of common stock granted on September 1, 2019 with an exercise price of $4.00/share, (iii) 22,222 shares of common stock and 6,674 shares of common stock granted on January 1, 2020 with an exercise price of $4.50/share, (iv) 2,333 shares of common stock granted on May 1, 2020 with an exercise price of $4.50/share, (v) 1,167 shares of common stock granted on July 1, 2020 with an exercise price of $4.50/share, and (vi) 14,448 shares of common stock granted on January 1, 2021 with an exercise price of $4.50/share. The options in footnote (1) were to expire 10 years from their respective grant dates. Mr. Bentovim was granted options to purchase an aggregate of 72,153 shares of the issuer's common stock under the 2016 Plan on March 1, 2023, consisting of (i) options to purchase 24,051 shares of common stock, at an exercise price of $3.00 per share, which options vest on March 1, 2025, (ii) options to purchase 24,051 shares of common stock, at an exercise price of $2.50 per share, which options vest on March 1, 2026, and (ii) options to purchase 24,051 shares of common stock, at an exercise price of $2.00 per share, which options vest on March 1, 2027. The foregoing options are set to expire seven years from the grant date. /s/ Lyron L. Bentovim 2024-03-05